Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06544-x
PubMed Identifier: 36127727
Publication URI: http://europepmc.org/abstract/MED/36127727
Type: Journal Article/Review
Volume: 23
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215